HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea (scientific article)

Genetic Characterization of Eight Full-Length HIV Type 1 Genomes from the Democratic Republic of Congo (DRC) Reveal a New Subsubtype, A5, in the A Radiation That Predominates in the Recombinant Structure of CRF26_A5U

Q56831276

Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage

Q56831316

Identification of a Newly Characterized HIV-1 BG Intersubtype Circulating Recombinant Form in Galicia, Spain, Which Exhibits a Pseudotype-Like Virion Structure

Q58006200

Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment

Q81511468

A new human immunodeficiency virus derived from gorillas

Q22251064

Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960

Q22251093

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

Q28474918

AIDS as a zoonosis: scientific and public health implications

Q29617393

Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Q30327384

Understanding the genetic diversity of HIV-1.

Q34087006

Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat

Q34127279

Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001.

Q37596583

Evidence of HIV-2 infection in Equatorial Guinea (central Africa): partial genetic analysis of a B subtype virus.

Q39064773

Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients

Q39461924

Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain

Q43032756

The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004.

Q44154850

HIV-1 subtypes and recombinants in the Republic of Congo

Q46163689

Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials

Q46699935

P433

issue

P921

main subject

Equatorial Guinea

Q983

drug resistance

Q12147416

anti-retroviral agent

Q50430310

P304

page(s)

1027-1031

P577

publication date

2010-09-01

P1433

published in

AIDS Research and Human Retroviruses

Q4651880

P1476

title

HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea

P478

volume

Reverse relations

cites work (P2860)

Q36084257	CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon
Q28533216	Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain
Q28553083	HIV-1 Variants and Drug Resistance in Pregnant Women from Bata (Equatorial Guinea): 2012-2013
Q30394967	High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo
Q28477624	Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population
Q35689037	Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses
Q30402586	Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon
Q45356911	Phylogenetic study of SIVcpz MT145 virus based on proteome and genome analysis
Q33740286	Spatiotemporal dynamics of the HIV-1 subtype G epidemic in West and Central Africa
Q50320002	Unravelling the complicated evolutionary and dissemination history of HIV-1M subtype A lineages
Q35455456	Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations